Form 4: Director Charles Bretz Receives Zeo ScientifiX Options
Statement of Changes in Beneficial Ownership
Director Charles Luther Bretz was granted 80,000 stock options in Zeo ScientifiX, Inc. as part of the company's 2021 Equity Incentive Plan.
Summary
- Director Charles Luther Bretz received a grant of 80,000 stock options for Zeo ScientifiX, Inc. (ZEOX) common stock.
- The options have an exercise price of $1.67 per share.
- The grant was issued under the company's 2021 Equity Incentive Plan.
- The options vested in full immediately upon the grant date of June 10, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative disclosure regarding director compensation, which is a routine corporate governance event.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Immediate vesting of options indicates confidence or fulfillment of prior service obligations.
Negatives
- Issuance of stock options results in potential future dilution for existing shareholders.
Risks
- Potential dilution of equity value if options are exercised.
- Market volatility affecting the value of the underlying common stock relative to the $1.67 exercise price.
Future Outlook
The filing does not provide specific forward-looking financial guidance, focusing solely on the disclosure of an equity grant to a director.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term performance and align leadership with shareholder outcomes.
Comparison to Industry Standards
- The use of an Equity Incentive Plan is consistent with standard compensation practices for publicly traded small-cap companies.
- Immediate vesting of director options is less common than multi-year vesting schedules but is occasionally used for compensation for past service or specific retention goals.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of 80,000 stock options to Director Charles Luther Bretz under the 2021 Equity Incentive Plan. | 06/10/2026 | Increases director's equity stake and potential for future dilution. |
Stakeholder Impact
- Shareholders may experience minor dilution upon the exercise of these options.
Next Steps
- Potential future exercise of options by the reporting person.
Key Dates
| Date | Description |
|---|---|
| 06/10/2026 | Grant date of stock options and date of earliest transaction. |
| 06/10/2031 | Expiration date of the granted stock options. |
| 06/12/2026 | Date of filing. |
Keywords
Zeo ScientifiX, ZEOX, Form 4, Stock Options, Insider Trading, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.